Laboratory Corp. (LH) Misses Q3 EPS by 2c; Guides FY12 EPS Below Views
Laboratory Corp. (NYSE: LH) reported Q3 EPS of $1.76, $0.02 worse than the analyst estimate of $1.78. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.44 billion.
Laboratory Corp. sees FY2012 EPS of $6.88-6.93, versus the consensus of $6.96.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Laboratory Corp. sees FY2012 EPS of $6.88-6.93, versus the consensus of $6.96.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.